ATRA ATRA
Company Profile ↓Company Overview
ATRA (ATRA) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 23.8% CAGR over the past five years.
Trades at an undemanding P/E of 3.3.
Maintains a net profit margin of 27.1%.
Recent Developments
- Dec 2025 Revenue of $120.77M (-6.3% YoY); net profit $32.69M.
- Trailing 12 Months Year-on-year growth — revenue -6.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 23.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 23.85% |
| 1 Year: | -6.33% |
Stock Price Performance
| 1 Year: | -24.56% |
| 6 Months: | +69.44% |
| 3 Months: | +79.41% |
| 1 Month: | -16.76% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)46.71 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 27.1%.
- Compounding revenue at 23.8% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 52.8% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 27.36M | 28.64M | 40.19M | 98.15M | 17.57M | 3.45M | 516.00K |
| Operating Income | -2.55M | -7.08M | -4.53M | -5.95M | -9.31M | -15.11M | -12.26M | -17.06M | -19.48M | -25.94M | -26.16M | -27.91M | -31.66M | -42.45M | -52.62M | -60.22M | -67.89M | -75.53M | -72.56M | -74.70M | -77.95M | -74.71M | -78.25M | -84.00M | -84.81M | -88.22M | -32.13M | -84.62M | -75.02M | -71.41M | -69.61M | -31.25M | -18.23M | -21.76M | 38.80M | 3.20M | -3.57M | -3.37M |
| Net Income | -2.54M | -7.05M | -4.51M | -5.92M | -9.16M | -14.95M | -11.87M | -16.56M | -18.88M | -25.37M | -25.65M | -27.43M | -31.10M | -41.44M | -50.88M | -58.36M | -66.26M | -74.33M | -71.89M | -73.51M | -77.46M | -74.35M | -78.33M | -83.79M | -84.66M | -88.11M | 18.47M | -84.09M | -74.77M | -71.11M | -69.80M | -31.75M | -19.05M | -21.91M | 38.01M | 2.39M | -4.30M | -4.14M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.91 | -0.90 | -0.87 | 0.18 | -0.82 | -0.72 | -16.91 | -16.40 | -5.65 | -3.10 | -2.93 | 3.50 | 0.19 | -0.32 | -0.29 |
| R&D Expense | - | - | - | - | 5.77M | 11.51M | 8.11M | 11.25M | 12.99M | 18.80M | 17.54M | 18.30M | 20.60M | 28.46M | 33.39M | 43.35M | 48.67M | 52.25M | 53.54M | 57.66M | 61.56M | 59.88M | 64.06M | 68.47M | 70.33M | 74.96M | 64.90M | 70.16M | 62.16M | 56.14M | 56.89M | 45.51M | 33.33M | 43.92M | 27.43M | 7.31M | 2.92M | 164.00K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | 63.57M | 8.57M | 128.94M | 120.77M |
| Operating Income | -8.62M | -28.16M | -58.45M | -81.24M | -121.53M | -237.11M | -295.68M | -309.05M | -340.46M | -280.51M | -276.01M | -83.44M | 35.86M |
| Net Income | -8.77M | -28.01M | -57.22M | -79.05M | -119.49M | -230.70M | -290.98M | -306.62M | -340.14M | -228.30M | -276.13M | -85.40M | 32.69M |
| Diluted EPS | - | - | - | - | - | - | - | -4.15 | -3.63 | -2.24 | -65.19 | -11.41 | 2.57 |
| R&D Expense | - | 15.45M | 41.62M | 56.51M | 81.21M | 167.46M | 216.10M | 244.65M | 282.00M | 272.53M | 224.78M | 151.48M | 37.45M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 51.83M | 106.12M | 324.98M | 263.91M | 217.78M | 391.84M | 342.94M | 588.12M | 468.13M | 376.42M | 165.50M | 109.10M | 20.23M |
| Total Equity | -3.73M | -11.02M | 103.18M | 315.10M | 253.74M | 177.86M | 339.22M | 290.78M | 462.34M | 279.61M | 126.64M | 99.23M | -97.28M | -38.50M |
| Cash & Equivalents | 4.21M | 51.62M | 21.90M | 23.75M | 47.97M | 79.22M | 60.70M | 74.32M | 200.40M | 106.08M | 92.94M | 25.84M | 25.03M | 8.48M |
| Total Liabilities | - | 1.75M | 2.94M | 9.88M | 10.18M | 39.91M | 52.98M | 52.16M | 125.78M | 188.51M | 249.78M | 264.74M | 206.38M | 58.74M |
| Current Liabilities | - | 1.52M | 2.72M | 9.71M | 9.68M | 27.65M | 39.98M | 36.74M | 82.90M | 105.79M | 78.92M | 142.23M | 134.57M | 14.92M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | -60.02M | -87.50M | -179.77M | -235.63M | -180.76M | -220.52M | -270.43M | -192.98M | -68.72M | -50.94M |
| Investing Cash Flow | - | - | - | 83.74M | 99.91M | -196.29M | 60.46M | -120.73M | 22.26M | 202.96M | 123.87M | 8.62M | 18.15M |
| Financing Cash Flow | - | - | - | 506.00K | 20.05M | 357.54M | 188.79M | 427.57M | 103.94M | 53.08M | 2.01M | 59.28M | 16.10M |
| Capital Expenditure | -3.00K | -46.00K | -290.00K | -3.02M | -20.23M | -35.92M | -5.73M | -4.51M | -10.58M | -4.19M | -1.22M | -246.00K | -0 |
| Free Cash Flow | - | - | - | -63.05M | -107.73M | -215.70M | -241.36M | -185.27M | -231.10M | -274.62M | -194.20M | -68.96M | -50.94M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - | - | -441.2% | -3,219.5% | -64.7% | 29.7% |
| Net Margin % | - | - | - | - | - | - | - | - | - | -359.1% | -3,220.9% | -66.2% | 27.1% |
| ROE % | 79.6% | -27.1% | -18.2% | -31.2% | -67.2% | -68.0% | -100.1% | -66.3% | -121.6% | -180.3% | -278.3% | 87.8% | -84.9% |
| ROCE % | -17.1% | -27.2% | -18.5% | -32.0% | -63.9% | -67.4% | -96.6% | -61.2% | -94.0% | -94.3% | -1,185.7% | 327.5% | 675.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ATRA
Understanding Momentum Shifts in (ATRA) - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNekhGdFdORWVGd2NsRjdnMHJFYUxXNkJhc2xNekxUT0hwTU00S085T3NkLVhmOVpRSmtOX1poR05oLVV5dHZ1dUtQUnpKUnZSZm9ON01zSm1RY0V5RG5yYXNYdXY3MWJrbmZDUkxzRzdHeEprZGFJTlRtOGpwMUwyQkdlcl9nLTZpR2RPVn…
ATRA Stock Shoots Up 82% in a Month: Here's What You Should Know - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQcHdldy1kSHNZQ0NtTmVwRjJ6TzlBeVA5Um5CSk5FX2hEWjBBYzFOcFNiWldmTE85ZTUyYlNxSzNFWFBkSkVhZV9kWGlIWUhrOGVFMlc1WEVGcjZaM0JmYmpiUkxJOWZPVzN1S3ZQalo4a1JhUFF5aEtySWpHTXZOT3JiN01XSS1qa3JONV…
Enterprise value to revenue forward of Atara Biotherapeutics, Inc. – NASDAQ:ATRA - TradingView
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNZFJjeHlsNnRiSG9GcUNCSjFxODh1QXJrcndpcmhhZ1FNc0t5d0dBMmVZc2FXWmpJamdjZ3V2ZkxqT1dadzFJeDZpTFJfdURFaHBqSFl1ZGZsRHNRcFdzTzdYbkl2cWZ6ekZzRDNKd3FweHI3Wl9GUi02d1d6ZXpYUjZ6TDEwNTV0VEp5NS…
ATRA|Atara Biotherapeutics Inc|Price:8.520|Chg%:+0.140 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5fQk80bUJTbkVtbjVZM1VxX19oMlh4c2JKdlkwZjJiYnNlc21aTDhucFVfR0VtanNYdlJFSHo5T3JMT2xRQTVTLVZHQy1qZmRIRmFHTE9Na1h6S1VHV1F0dEpHYUlVOUpkT2xLcU1B?oc=5" target="_blank">ATRA|Atara Biothera…
ATRA Stock Sees Biggest Single-Day Gain In Over 2 Years, Breaches Key Technical Milestone – New FDA Update Has Bulls Circling Back - Stocktwits
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQX0ZabjBjZzZ6UDZpZlJ1dUhObUpwQ3ZNbWdDVzN4WXdwd3pyTDBpdlhub3VkMWlhQnJZeDYzODlSS0FEQUFSTFpzODhDUkJjZFhqTzVNbWhxQ1ZLb1ZBdFdTQzBUdHFiSnFRQmIydC0xS3pKa0kxY1VHcUtZQmJrS1hBcmJPLWtEMTdXNF…
Atara presses FDA meeting on T-cell therapy for ultra-rare PTLD - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxNZXFQZE1IelBjRzhoaVV1aGtvM1U2UjFPd2lNaUlGSXNGc2g3NVBDanU1QmQ2cy1aODFfVWVRQW1wWWw0aE81Y1hVdWs4VGZFMTFMUXI2RmI2c0ZQRWpWaUlMUXlTdjF5RS1lcnB3UzZSeFE2T1JRdTBMaVc4MFhYaFpFRHR4VmJZOEhwQ2…
ATRA — Frequently Asked Questions
What is the current share price of ATRA?
As of 2026-08-05 17:25 PDT, ATRA trades at $8.54 on NASDAQ/NYSE. Its 52-week range is $4.18 to $18.09.
What is the P/E ratio of ATRA?
ATRA trades at a trailing price-to-earnings (P/E) ratio of 3.32.
What is the return on equity (ROE) of ATRA?
ATRA has a return on equity (ROE) of -84.90%.
Is ATRA a good stock to buy?
This page provides a data-driven analysis of ATRA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.